Comments
City-based pharma player, Claris Lifesciences Limited reported consolidated net loss of Rs 13 crore for the second quarter ended September 2015, as against profit of Rs 20 crore reported in the same period last year.
Company's consolidated net sales for the second quarter stood at Rs 197 crore, up by 19 per cent from Rs 166 crore in the corresponding quarter a year ago.
EBITDA for the quarter reduced to Rs 47 crore from Rs 51 crore. EBITDA de-growth is due to the R&D expensing out, the company informed.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.